FFT Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

FFT Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$729K	Hold	4,609	–	–	0.11%	57
2026 Q1	$589K	Sell	4,609 -61	-1%	-$7.62K	0.11%	65
2025 Q4	$569K	Sell	4,670 -365	-7%	-$41.9K	0.11%	58
2025 Q3	$505K	Hold	5,035	–	–	0.09%	68
2025 Q2	$430K	Sell	5,035 -7,240	-59%	-$578K	0.08%	73
2025 Q1	$996K	Sell	12,275 -4,816	-28%	-$430K	0.21%	51
2024 Q4	$1.54M	Sell	17,091 -1,025	-6%	-$99.3K	0.12%	51
2024 Q3	$1.79M	Sell	18,116 -2,763	-13%	-$271K	0.14%	49
2024 Q2	$1.94M	Sell	20,879 -1,511	-7%	-$135K	0.17%	43
2024 Q1	$2.12M	Sell	22,390 -685	-3%	-$63.6K	0.18%	42
2023 Q4	$2.06M	Sell	23,075 -882	-4%	-$65.5K	0.18%	37
2023 Q3	$1.75M	Sell	23,957 -1,762	-7%	-$141K	0.23%	31
2023 Q2	$2.14M	Sell	25,719 -17,405	-40%	-$1.46M	0.27%	28
2023 Q1	$3.29M	Sell	43,124 -8,084	-16%	-$671K	0.41%	25
2022 Q4	$4.25M	Buy	51,208 +7,467	+17%	+$605K	0.55%	25
2022 Q3	$3.47M	Buy	43,741 +6,799	+18%	+$573K	0.48%	21
2022 Q2	$2.74M	Buy	36,942 +31,915	+635%	+$2.4M	0.31%	25
2022 Q1	$452K	Buy	+5,027	New	+$464K	0.04%	40

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

FFT Wealth Management's XBI Position: Q2 2026 in Review

FFT Wealth Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 4,609 shares worth $729K. The position accounts for 0.11% of the portfolio, ranked #57.

FFT Wealth Management first reported a position in XBI in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.25M in Q4 2022. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

FFT Wealth Management held 4,609 shares of State Street SPDR S&P Biotech ETF worth $729K as of Q2 2026.
FFT Wealth Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.11% of FFT Wealth Management's portfolio in Q2 2026, its #57 holding.
FFT Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 18 quarters since.
FFT Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $4.25M in Q4 2022.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on FFT Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.